|Day Low/High||105.61 / 107.07|
|52 Wk Low/High||81.22 / 114.26|
The German chemicals company sticks with its forecast for a slight fall in full-year operating profit and a significant decline in sales.
TheStreet highlights 3 stocks pushing the chemicals industry higher today.
Monsanto (MON) stock is reacting favorably to the European Commission's import approval of new genetically modified soybeans for food and livestock feed.
Monsanto Company (NYSE: MON) announced today that the European Commission has granted import approval for Roundup Ready 2 Xtend ® soybeans.
Results from the ChemChina bid target come on the heels of disappointing figures from former suitor Monsanto.
Cramer says he's frustrated with Synergy Pharmaceuticals' situation.
The higher the market goes, so, too, will your risks, Cramer says.
It was the tale of two earnings seasons on Tuesday and Wall Street was stuck in the middle.
Stocks fluctuate late Tuesday as earnings reports are mixed.
Aetna and Humana each traded down sharply as antitrust hurdles may block $34 billion merger.
Monsanto (MON) has rejected Bayer's bid for the second time calling it "financially inadequate."
IMF cuts growth estimates for the U.K. by almost 1 percentage point for 2017.
A rush of earnings kept investors busy throughout the morning. Netflix was one of the biggest drags on the Nasdaq and S&P 500.
The St. Louis-based target claims Bayer's revised $63.5 billion bid remains 'financially inadequate."
Stocks are off session lows by mid-morning Tuesday with the Dow Jones Industrial Average trying for gains after a rush of key earnings.
Monsanto Company (NYSE: MON) today announced that its Board of Directors unanimously views Bayer AG's revised proposal as financially inadequate and insufficient to ensure deal certainty.
Monsanto (MON) stock is higher in afternoon trading on Monday as the company is reportedly negotiating a confidentiality agreement with Bayer (BAYRY).
A huge break fee and debt financing might convince Monsanto to open its books but the German bidder probably won't dig much deeper.
The attack in France has cast a pall over U.S. futures, but data from China has investors there bubbly.
The S&P 500 closed out Thursday's session with its fourth record close in a row as hopes for global monetary stimulus kept hopes high on Wall Street.
What a week. The S&P 500 closed out Thursday's session with its fourth record close in a row as hopes for global monetary stimulus kept hopes high on Wall Street.
The S&P 500 comes off session highs by Thursday afternoon, though remains on track for a record close for the fourth time this week.
Monsanto Company (NYSE: MON) acknowledged that it has received a revised, non-binding proposal from Bayer AG for a potential acquisition of Monsanto.
Bank of England defies market expectations and keeps rate at 0.5%; expects easing in August.
Bayer AG (BAYRY) is increasing its offer for a takeover of Monsanto (MON).
Trade-Ideas LLC identified Monsanto (MON) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
Monsanto shares are rising Thursday following news that the company has revived talks with Germany's BASF about a possible combination of their agrochemicals businesses.
Monsanto (MON) might be looking to acquire BASF SE’s (BASFY) agriculture-solutions unit.